DEXCOM INC·4

May 27, 4:12 PM ET

Coleman Jon 4

4 · DEXCOM INC · Filed May 27, 2025

Insider Transaction Report

Form 4
Period: 2025-05-22
Coleman Jon
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-05-22+68,73868,738 total
Footnotes (1)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

Documents

1 file
  • 4
    wk-form4_1748376728.xmlPrimary

    FORM 4